|
MLYS Mineralys Therapeutics Inc 1933414 |
| Balance Sheet |
|
Current Assets
|
205,351,000 |
|
Assets
|
205,903,000 |
|
Current Liabilities
|
14,646,000 |
|
Liabilities
|
14,646,000 |
|
Equity
|
191,257,000 |
|
Shares Out
|
49,727,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-166,314,000 |
|
Investing Cash Flow
|
114,959,000 |
| Market Analysis |
Market Cap
|
587,271,993 |
|
Price
|
16.96 |
|
BVPS
|
3.85 |
|
PB
|
4.38 |
|
EPS
|
-2.71 |
|
PS
|
5.15 |
|
FCF
|
-51,355,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/12 |
-3.66 |
3/21 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLYS documents filed with the SEC.
MLYS Filings
Clear
